--Goldman Sachs Adjusts Alector's Price Target to $6 from $9, Keeps Sell Rating
10:19AM ET 5/24/2022 MT NewswiresPrice: 8.77, Change: -0.47, Percent Change: -5.09 ...
Price: 8.77, Change: -0.47, Percent Change: -5.09 ...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Alector (ALEC) shares were down nearly 2% in Wednesday afternoon trade after Goldman Sachs initiated coverage of the stock at sell while setting the price...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Alector (ALEC) said Tuesday that it has named Dr. Gary Romano as chief medical officer, effective May 23. According to the company, Romano will lead the...
Alector (ALEC) said Tuesday its drug AL001 for the potential treatment for frontotemporal dementia patients with a C9orf72 genetic mutation was generally...
Alector (ALEC) shares were down almost 15% in Tuesday midday trading after Stifel downgraded the stock to hold from buy and cut its price target to $18...
Alector (ALEC) has an average rating of outperform and price targets ranging from $18 to $54, according to analysts polled by Capital IQ. (MT Newswires...
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Alector (ALEC) said Monday it appointed Marc Grasso as chief financial officer to succeed Linda Rubinstein, who has been working as the clinical-stage...